These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18987382)

  • 1. Ivabradine for stable angina?
    Drug Ther Bull; 2008 Nov; 46(11):84-8. PubMed ID: 18987382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine for chronic heart failure?
    Drug Ther Bull; 2012 Oct; 50(10):117-20. PubMed ID: 23065752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK; Gray D; Purcell H
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
    Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ivabradine--a medical alternative for patients with chronic stable angina pectoris].
    Haghfelt TH
    Ugeskr Laeger; 2006 Nov; 168(46):3991-3. PubMed ID: 17125651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new medicine for treatment of stable angina pectoris].
    Ter Arkh; 2006; 78(5):95. PubMed ID: 16889061
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L; Filipova S; Martos R
    Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug insight: If inhibitors as specific heart-rate-reducing agents.
    Borer JS
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):103-9. PubMed ID: 16265314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N
    Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.